Glucosamine Sulfate Sodium Chloride And Glucosamine Hydrochloride Were Accepted For CDE Registration
Abstract.：On December 11, 2023, The company's application for listing of Glucosamine Sulfate Sodium Chloride was accepted and registered by the National Medical Products Administration with acceptance number CYHS2360915 and registration number Y20230001033.
On December 11, 2023, The company's application for listing of Glucosamine Sulfate Sodium Chloride was accepted and registered by the National Medical Products Administration with acceptance number CYHS2360915 and registration number Y20230001033.
On December 27, 2023, the company's application for listing of Glucosamine Hydrochloride was accepted and registered by the National Medical Products Administration with acceptance number CYHS2360979 and registration number Y20230001032.
On December 27, 2023, the company's application for listing of Glucosamine Hydrochloride was accepted and registered by the National Medical Products Administration with acceptance number CYHS2360979 and registration number Y20230001032.
NEWS INFORMATION
